IBEX (NASDAQ:IBEX) Insider Sells $51,460.00 in Stock

IBEX Limited (NASDAQ:IBEX) insider Christina O’Connor sold 1,000 shares of the business’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $51.46, for a total value of $51,460.00. Following the transaction, the insider owned 37,424 shares of the company’s stock, valued at $1,925,839.04. This trade represents a 2.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Christina Al Trofimuk-O’connor also recently made the following trade(s):

• On Wednesday, September 16th, Christina O’Connor sold 2,376 shares of IBEX stock. The stock was sold at an average price of $39.34, for a total value of $93,471.84.
• On Tuesday, September 15th, Christina O’Connor sold 7,500 shares of IBEX stock. The shares were sold at an average price of $40.30, for a total value of $302,250.00.

IBEX Price Performance

Shares of IBEX traded up $1.95 during trading hours on Tuesday, reaching $52.23. 432,801 shares of the company’s stock traded hands, compared to its average volume of 124,838. IBEX Limited has a twelve month low of $25.94 and a twelve month high of $52.29. The business’s fifty day simple moving average is $43.25 and its two-hundred day simple moving average is $34.57. The firm has a market capitalization of $696.75 million, a price-to-earnings ratio of 15.83 and a beta of 0.74.

IBEX (NASDAQ:IBEX) last released its earnings results on Thursday, November 5th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.20. IBEX had a return on equity of 28.96% and a net margin of 7.19%. The firm had revenue of $175.23 million during the quarter, compared to the consensus estimate of $169.31 million.

Hedge Funds Weigh In On IBEX

A number of hedge funds have recently modified their holdings of the stock. Lazard Asset Management LLC raised its holdings in shares of IBEX by 55.2% during the first quarter. Lazard Asset Management LLC now owns 89,150 shares of the company’s stock worth $2,391,000 after acquiring an additional 31,697 shares in the last quarter. Globeflex Capital L P purchased a new position in IBEX in the second quarter valued at about $3,112,000. Tieton Capital Management LLC purchased a new position in IBEX in the second quarter valued at about $8,353,000. Watershed Asset Management L.L.C. acquired a new position in IBEX in the 1st quarter worth about $453,000. Finally, Dimensional Fund Advisors LP increased its position in IBEX by 7.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 358,191 shares of the company’s stock worth $9,607,000 after purchasing an additional 24,942 shares during the last quarter. 81.24% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about IBEX

Here are the key news stories impacting IBEX this week:

• Positive Sentiment: IBEX CEO Bob Dechant and CFO Taylor Greenwald are scheduled to present at the RBC 2026 Global TIMT Conference on November 17. The event offers an opportunity to discuss the business and its outlook, though no new financial guidance was announced. Conference announcement
• Neutral Sentiment: A short-interest report lists zero shares sold short as of November 10, despite characterizing short interest as having increased. If the zero figure is accurate, it indicates little reported short positioning; the conflicting description makes the update difficult to interpret.
• Negative Sentiment: RBC raised its price target to $45 from $40 but maintained a “sector perform” rating. The new target is below the recent share price, implying potential downside and suggesting the analyst sees limited near-term upside at current levels.
• Negative Sentiment: Six IBEX insiders, including CEO Dechant, reported share sales totaling about 31,200 shares. Dechant’s 5,000-share transaction was made under a pre-arranged Rule 10b5-1 plan, and sellers retained shares after their trades; nonetheless, the cluster of sales could weigh on sentiment. CEO filing Insider filing Insider filing Insider filing Insider filing Director filing

Analyst Ratings Changes

IBEX has been the subject of several research analyst reports. Robert W. Baird upped their price target on shares of IBEX from $40.00 to $44.00 and gave the company a “neutral” rating in a research report on Monday, September 28th. Weiss Ratings raised shares of IBEX from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, October 12th. Royal Bank Of Canada increased their price target on shares of IBEX from $40.00 to $45.00 and gave the stock a “sector perform” rating in a research report on Tuesday. Finally, Wall Street Zen upgraded shares of IBEX from a “buy” rating to a “strong-buy” rating in a report on Saturday. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $44.50.

About IBEX

IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services. The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.